Article
An in-silico approach aimed to clarify the role of Y181C and K103N HIV-1 reverse transcriptase mutations versus Indole Aryl Sulphones.
Journal of molecular graphics & modelling - 1 Jan 2016
Massarotti Alberto, Coluccia Antonio
Abstract excerpt
The emergence of HIV-1 drugs resistant stains remains of pivotal interest in relation to drugs development. Non nucleoside reverse transcriptase inhibitors proven to be very effective versus HIV-1 wild type but, with the only exception of diarylpyrimidines (e.g., etravirine, 1), were featured by high-level resistance versus mutated RT. The effects of two of the most clinically relevant RT mutations (Y181C; K103N)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
